FEMINATI – tablets, No. 28

FEMINATI – tablets, No. 28

Medicinal product
FEMINATI – tablets, No. 28

1 yellow tablet (active) contains:

  • ethinylestradiol 0.03 mg
  • drospirenone 3 mg

1 white tablet (placebo) contains:

  • no active ingredients

Tablets, No. 28 (21+7)

Tablets for oral use.

The tablets should be taken daily at the same time with a small amount of liquid, according to the order indicated on the blister pack. Do not take breaks when using Feminati tablets. Take 1 tablet per day for 28 days. You should start taking tablets from each subsequent pack after taking the last tablet from the previous pack. Menstrual-like bleeding usually begins on the 2nd or 3rd day after starting to take the placebo tablets (white) and may not end before you start taking tablets from the next pack.

The package includes a blister holder, in which you can place the blister when taking it with you, and a calendar scale.

The blister pack contains 21 tablets with active ingredients (yellow) and 7 placebo tablets without active ingredients (white).

  • Oral contraception
  • Regulates the menstrual cycle
  • Reduces pain and blood loss during menstruation
  • Eases premenstrual syndrome (PMS) symptoms
  • Supports healthy libido
  • Minimizes fluid retention and prevents weight gain
  • Improves lipid profile and overall metabolic health
  • Enhances skin and hair condition, reducing acne, seborrhea, excessive hair growth, and hair loss
  • Effective contraception
  • Monophasic low-dose formula — provides stable hormone levels, reducing side effects
  • Pronounced antimineralocorticoid effect — reduces fluid retention and bloating
  • Good tolerability
  • European manufacturer

3 years from the date of manufacture

Laboratorios León Pharma, S.A. Manufacturer’s location and address of business: La Vallina, s/n, Industrial Zone Navatejera, Villacillambre, 24193, Spain / on behalf of SIA “Vorvarts Pharma”, 15 Krisjana Barona Street, Riga, LV-1011, Latvia